GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 926 - 950 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgG Patient 1 22 moderate
G32473MI
55
IgG Patient 1 22 moderate
G91537AT
55
IgM Patient 1 10 moderate
G02670IJ
55
IgM Patient 1 10 moderate
G24617OK
55
IgM Patient 1 10 moderate
G92823JK
55
IgM Patient 2 15 mild
G38488WF
55
IgM Patient 1 6 moderate
G35446HX
55
IgM Patient 1 6 moderate
G38488WF
55
IgG Patient 3 -180 mild
G81315DD
55
IgG Patient 3 11 mild
G92823JK
55
IgG Patient 3 4 mild
G92022ML
55
IgG Patient 4 12 mild
G21320TF
55
IgG Patient 4 12 mild
G78255UI
55
IgG Patient 1 10 moderate
G08340FW
56
IgG Patient 1 10 moderate
G42666HT
56
IgG Patient 1 22 moderate
G47566FL
56
IgM Patient 1 10 moderate
G58969RU
56
IgM Patient 1 22 moderate
G40696TO
56
IgM Patient 1 22 moderate
G63074CQ
56
IgG Patient 2 24 mild
G36191CD
56
IgM Patient 2 15 mild
G78074HX
56
IgM Patient 2 15 mild
G94435QH
56
IgG Patient 1 6 moderate
G60761LT
56
IgM Patient 1 6 moderate
G66937TJ
56
IgM Patient 1 6 moderate
G94576MN
56

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024